Fed. Circ. OKs Novartis Loss In Eye Syringe Patent Feud
By Adam Lidgett · September 23, 2024, 6:24 PM EDT
The Federal Circuit has backed a Patent Trial and Appeal Board finding that more than two dozen claims in a Novartis pre-filled eye injection syringe patent weren't patentable....
To view the full article, register now.